Tuesday, August 02, 2011

On Migraine.com: Migraine Medication Telcagepant is Officially Dead


New to Somebody Heal Me? Subscribe to the Somebody Heal Me feed:
Subscribe in a reader or subscribe by e-mail. Follow me on Twitter @somebodyhealme.

I've written an article for Migraine.com about the demise of Merck's investigational migraine treatment medication telcagepant and the status of other CGRP receptor antagonists, which many people think are the future of of migraine treatment.

Migraine Medication Telcagepant is Officially Dead

Sources:
Merck kills PhIII Drug Program
Calcium Gene-Related Peptide Receptor Antagonists in the Treatment of Migraine
Olcegepant: Novel Therapy for Acute Migraine

Related Posts:
Migraine Drug Telcagepant to Undergo Another Clinical Safety Study
News: Telcagepant to be Abandoned by Merck?
Telcagepant & The Future of Migraine Prevention
Possible Genetic Explanation for Migraine
Migraine News Roundup 34


Subscribe to the Somebody Heal Me feed: Subscribe in a reader or subscribe by e-mail. Follow me on Twitter @somebodyhealme

Photo Sharing and Video Hosting at Photobucket Content by Diana E. Lee.

DISCLAIMER: Nothing on this site constitutes medical or legal advice. I am a patient who is engaged and educated and enjoys sharing my experiences and news about migraines, pain and depression. Please consult your own health care providers for advice on your unique situation.